IFNAR1 and pancreatic neoplasm: Type I IFNs are antitumor cytokines and modulators of innate immune activation that have recently been shown to cause radiosensitization in pancreatic cancer, and they all bind to the cell surface receptor complex (IFNAR) (39, 43, 57).